Company Active LTD

Company profile

New Wave Biotech Ltd

Alt Protein Downstream Process Optimisation | New Wave Biotech

New Wave Biotech optimizes downstream processing with virtual experimentation for precision fermentation, so alt protein companies can scale quicker, cheaper & faster.

CRN
14555913
Founded
2022
Age
3

Overview

Legal name
NEW WAVE BIOTECH LTD
Region
Unknown
Registered address
INTERNATIONAL HOUSE
61 MOSLEY STREET
MANCHESTER
ENGLAND
M2 3HZ
Insolvency history
No

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
5

Company events

Reference milestones and recent Companies House filing stream events.

5 events
05 Jan
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

22 Dec
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

23 Dec
2022

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2023
Funded years
2023, 2024
Age at first award
0 years

Projects

2024 CR&D Bilateral Lead participant

Development of innovative food products using plant proteins and precision fermentation with in-silico optimisation

1 Oct 2024 to 31 Mar 2026

Awarded
£405,481
Total cost £579,259

The food ingredient market has evolved in recent years, leveraging more technologies to customise and functionalise ingredients for different end uses. Techniques such as biomass and precision fermentation, cell-cultivation techniques and structure modification have led to a new wave of ingredients offering premium-tier functionality. This project aims to...

2023 Collaborative R&D Lead participant

Biomanufacturing downstream process optimisation and scaling with in-silico experimentation

1 Dec 2023 to 31 Dec 2024

Awarded
£155,342
Total cost £221,917

New Wave Biotech (NWB) is developing software that uses computational modelling to optimise downstream processes (DSP) for biomanufacturing, accelerating R&D and reducing final production costs of alternative proteins and other synthetic biology products. This solution transforms how DSP optimisation and scaling is done -- moving it from a slow, expensive...

2023 Grant for R&D Lead participant

Automated Technoeconomic Analysis for Biomanufacturing Optimisation

1 Jun 2023 to 31 Oct 2023

Awarded
£49,862
Total cost £49,862

New Wave Biotech (NWB) is developing software that uses computational modelling to optimise downstream processes (DSP) for biomanufacturing, accelerating R&D and reducing final production costs of alternative proteins and other synthetic biology products. This solution transforms how DSP optimisation is done -- moving it from a slow, expensive and ineffic...

Product types

Collaborative R&D CR&D Bilateral Grant for R&D